Alpine Immune Sciences (ALPN) Misses Q3 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ALPN Hot Sheet
Join SI Premium – FREE
Alpine Immune Sciences (NASDAQ: ALPN) reported Q3 EPS of ($0.42), $0.33 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $8.37 million versus the consensus estimate of $18.69 million.
For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TransUnion (TRU) Tops Q3 EPS by 4c; Offers FY26 EPS Guidance
- Hilton (HLT) Tops Q3 EPS by 10c, Misses on Revenue; Offers Guidance
- Provident Financial Holdings (PROV) Misses Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
